v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Total revenues $ 9,277 $ 34,470 $ 43,582 $ 108,215
Costs and operating expenses:        
Cost of product revenue 2,249 9,786 9,947 29,577
Research and development 13,662 21,821 47,651 60,410
Selling, general and administrative 12,302 13,499 41,066 39,859
Restructuring charges 3,140 0 3,284 0
Asset impairment and other charges 9,984 0 9,984 0
Total costs and operating expenses 41,337 45,106 111,932 129,846
Loss from operations (32,060) (10,636) (68,350) (21,631)
Interest income 1,056 436 3,266 618
Other income (expense), net (3,895) 216 (3,930) 150
Loss before income taxes (34,899) (9,984) (69,014) (20,863)
Provision for income taxes 9 8 34 125
Net loss $ (34,908) $ (9,992) $ (69,048) $ (20,988)
Net loss per share, basic (in dollars per share) $ (0.50) $ (0.15) $ (1.02) $ (0.32)
Net loss per share, diluted (in dollars per share) $ (0.50) $ (0.15) $ (1.02) $ (0.32)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 69,466 65,426 67,670 65,271
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 69,466 65,426 67,670 65,271
Product revenue        
Revenues:        
Total revenues $ 5,395 $ 28,042 $ 24,807 $ 93,376
Research and development revenue        
Revenues:        
Total revenues $ 3,882 $ 6,428 $ 18,775 $ 14,839

Source